Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-03-21 @ 7:19 PM
Study NCT ID:
NCT05433194
Status:
UNKNOWN
Last Update Posted:
2023-02-08
First Post:
2022-06-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)
Sponsor:
Suzhou Abogen Biosciences Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ABO1009-DP-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None